Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (ACTRN12625001072404) titled 'Intravenous Lignocaine for Acute Migraine' on Oct. 1.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Non-randomised trial
Masking: Open (masking not used)
Assignment: Single group
Type of endpoint: Safety/efficacy
Primary Sponsor: Wide Bay Hospital and Health Service
Condition:
Migraine
Migraine
Emergency medicine - Other emergency care
Neurological - Other neurological disorders
Intervention:
Medications will be administered by the nurse involved in the patients care. Total dose, timing and any side effects will be documented in the case report form.
Intravenous lignocaine 1.5...